News

Cell Therapeutics (CTI) previously received approximately $6.5 million on March 2, 2009, related to this transaction, and the remaining $3.5 million, subject to adjustments for expenses and revenues,

In October 2008, OctoPlus announced a strategic focus on developing controlled release versions of existing or new drugs for clients, in addition to providing general formulation development and

eClinicalWorks’s electronic medical record (EMR) solution provides the ability to manage patient flow, access patient records in-house or remotely, communicate electronically with referring physicians, and send secure consult

Under the terms of the agreement, Allscripts and dbMotion will develop joint solutions to present information in a seamless way to clinicians. Allscripts will offer the dbMotion solution

The court determined that Chondrometrics software would not make use of claims one and 11 of the ArthroVision’s patent. ArthroVision plans to promptly appeal in full the not

The trial, which is being conducted at 15 academic and private medical centers in the US and Europe, will evaluate the safety and effectiveness of the Linx system

Kai Pharmaceuticals, a drug discovery and development company, has initiated a second Phase IIa study of KAI-1678, an isozyme-selective, small peptide inhibitor of the epsilon protein kinase C

In this new role, Mr Gold will be responsible for client relationships, new business development, and the positioning and promotion of MedQuist. Most recently, Mr Gold was the

According to Eisai, Gliadel wafer is the only FDA-approved chemotherapeutic implant for use during surgical procedures for malignant glioma. Gliadel wafer has been approved in 18 countries worldwide,